PHOENIX: Since Alois Alzheimer first described a “peculiar severe disease” in 1901, research into dementia has grown at an astonishing rate. As the prevalence of Alzheimer’s disease increases, the need for a treatment becomes more pressing and scientists trying to understand the disease are more accountable than ever. While there has been significant investment and encouraging progress, therapies are still limited. And as the pressure on those affected by and working in the field of Alzheimer’s intensifies, therapeutic goals seem increasingly elusive and sometimes contradictory.